The short answer

GLP-1 drugs work in four places at once — not just your stomach. They copy a natural hormone your gut makes after you eat, and that hormone tells your body to do four things: release insulin when blood sugar is high, switch off the hormone that raises blood sugar, slow your stomach down, and turn down hunger in your brain. "Slows digestion" is only one of the four — and it is not even the main reason people lose weight. Here is the full picture, in plain English.

First, what GLP-1 actually is

GLP-1 stands for glucagon-like peptide-1 — a natural hormone. Cells in your small intestine release it within minutes of eating. It is what scientists call an incretin: a gut signal that tells the rest of your body "food is arriving, get ready."

Your own GLP-1 is powerful, but it breaks down within a couple of minutes. The medications — semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) — are engineered copies that resist that breakdown and keep working for about a week. That is why most are once-weekly injections.

What it does, step by step — the four jobs

1. It tells your pancreas to release insulin — but only when you need it

When blood sugar rises after a meal, GLP-1 prompts your pancreas to release insulin, which moves sugar out of your blood. The clever part: this is glucose-dependent — it mostly happens when blood sugar is high and eases off when it is normal. That built-in brake is why GLP-1 drugs on their own rarely cause dangerously low blood sugar. This is the main effect for type 2 diabetes.

2. It switches off glucagon — the hormone that raises blood sugar

Your body also makes glucagon, which tells your liver to release stored sugar into your blood. GLP-1 suppresses glucagon — and this accounts for about half of the blood-sugar-lowering effect. Less sugar released by the liver, plus more sugar cleared by insulin, equals steadier blood sugar.

3. It slows your stomach — the part everyone has heard of

GLP-1 slows how fast your stomach empties into your intestine. Food sits longer, so you feel full sooner and stay full longer, and the sugar from a meal trickles in slowly instead of spiking. This is also why nausea and feeling overly full are the most common side effects — the very mechanism that helps can be uncomfortable. (See how to stop nausea on GLP-1.)

4. It turns down hunger in your brain

This is the big one for weight loss, and the most under-appreciated. GLP-1 acts directly on the appetite centers of your brain (the hypothalamus), increasing the feeling of fullness and reducing hunger and cravings — what many people describe as quieting the "food noise." You simply want to eat less. The weight loss comes mostly because you eat less, driven by the brain — not just because food moves through slowly.

Why tirzepatide (Mounjaro / Zepbound) is a little different

Semaglutide drugs (Ozempic, Wegovy) copy one hormone receptor: GLP-1. Tirzepatide (Mounjaro, Zepbound) is a dual drug — it copies GLP-1 and a second incretin hormone called GIP. Working two channels at once is part of why tirzepatide tends to produce more weight loss in studies. (See our Ozempic vs Wegovy vs Zepbound comparison.)

Why this explains so much about your experience

Once you see the four jobs, a lot of what people feel makes sense:

  • Why your hunger and "food noise" go quiet → the brain effect (#4).
  • Why you feel full fast, and sometimes queasy → the slowed stomach (#3).
  • Why blood sugar improves without crashing → glucose-dependent insulin (#1) plus glucagon switched off (#2).
  • Why weight can return if you stop → remove the drug and the appetite signal comes back. (See what happens when you stop a GLP-1.)

What this means for you

GLP-1 drugs are not "fat-burning" pills, and they do not block calories. They work by retuning the natural signals that control your blood sugar and appetite. That is also why the habits you build alongside them — enough protein, staying active — matter so much for keeping muscle and holding onto results. (See preventing muscle loss on GLP-1.)

If you are a senior weighing whether a GLP-1 is right for you, the next question is usually whether Medicare will cover it. Our 2-minute eligibility quiz and the Medicare GLP-1 guide walk through coverage, and the provider directory lists clinicians who prescribe them.

Data note

Data as of June 2026. This describes the general, well-established way GLP-1 receptor agonists work; individual drugs and individual responses vary. It is educational, not medical advice — talk to your doctor about whether a GLP-1 is right for you.